Literature DB >> 20702674

Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer 2.

Andrew M Borman1, Christopher J Linton, Debra Oliver, Michael D Palmer, Adrien Szekely, Elizabeth M Johnson.   

Abstract

Rapid identification of yeast species isolates from clinical samples is particularly important given their innately variable antifungal susceptibility profiles. Here, we have evaluated the utility of pyrosequencing analysis of a portion of the internal transcribed spacer 2 region (ITS2) for identification of pathogenic yeasts. A total of 477 clinical isolates encompassing 43 different fungal species were subjected to pyrosequencing analysis in a strictly blinded study. The molecular identifications produced by pyrosequencing were compared with those obtained using conventional biochemical tests (AUXACOLOR2) and following PCR amplification and sequencing of the D1-D2 portion of the nuclear 28S large rRNA gene. More than 98% (469/477) of isolates encompassing 40 of the 43 fungal species tested were correctly identified by pyrosequencing of only 35 bp of ITS2. Moreover, BLAST searches of the public synchronized databases with the ITS2 pyrosequencing signature sequences revealed that there was only minimal sequence redundancy in the ITS2 under analysis. In all cases, the pyrosequencing signature sequences were unique to the yeast species (or species complex) under investigation. Finally, when pyrosequencing was combined with the Whatman FTA paper technology for the rapid extraction of fungal genomic DNA, molecular identification could be accomplished within 6 h from the time of starting from pure cultures.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702674      PMCID: PMC2953101          DOI: 10.1128/JCM.01071-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Identification of medically important fungi by the Pyrosequencing technology.

Authors:  B Gharizadeh; E Norberg; J Löffler; S Jalal; J Tollemar; H Einsele; L Klingspor; P Nyrén
Journal:  Mycoses       Date:  2004-02       Impact factor: 4.377

Review 3.  Nosocomial Candida. Epidemiology, transmission, and prevention.

Authors:  W L Wright; R P Wenzel
Journal:  Infect Dis Clin North Am       Date:  1997-06       Impact factor: 5.982

4.  Azole drug resistance in yeasts.

Authors:  E M Johnson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1995-11       Impact factor: 5.790

5.  [26S rDNA D1/D2 domain sequence analysis of the pathogenic strain from the first case of disseminated trichosporonosis in China].

Authors:  R Yang; D Li; J Zhao
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2001-04-25

6.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

Authors:  M A Pfaller; R N Jones; G V Doern; A C Fluit; J Verhoef; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

8.  High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

Authors:  D Law; C B Moore; H M Wardle; L A Ganguli; M G Keaney; D W Denning
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

9.  Shifting patterns in the epidemiology of nosocomial Candida infections.

Authors:  David R Snydman
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

Review 10.  Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

View more
  17 in total

1.  Droplet-based pyrosequencing using digital microfluidics.

Authors:  Deborah J Boles; Jonathan L Benton; Germaine J Siew; Miriam H Levy; Prasanna K Thwar; Melissa A Sandahl; Jeremy L Rouse; Lisa C Perkins; Arjun P Sudarsan; Roxana Jalili; Vamsee K Pamula; Vijay Srinivasan; Richard B Fair; Peter B Griffin; Allen E Eckhardt; Michael G Pollack
Journal:  Anal Chem       Date:  2011-10-14       Impact factor: 6.986

2.  Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom.

Authors:  Andrew M Borman; Adrien Szekely; Michael D Palmer; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

3.  Development of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.

Authors:  Xiaobo Feng; Jingsong Wu; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

4.  Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.

Authors:  Andrew M Borman; Julian Muller; Jo Walsh-Quantick; Adrien Szekely; Zoe Patterson; Michael D Palmer; Mark Fraser; Elizabeth M Johnson
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Molecular identification and antifungal susceptibility testing of clinical isolates of the Candida rugosa species complex and proposal of the new species Candida neorugosa.

Authors:  Katihuska Paredes; Deanna A Sutton; Josep Cano; Annette W Fothergill; Sara D Lawhon; Sean Zhang; Jeffrey P Watkins; Josep Guarro
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

6.  Evaluation of the commercial rapid trehalose test (GLABRATA RTT) for the point of isolation identification of Candida glabrata isolates in primary cultures.

Authors:  Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal:  Mycopathologia       Date:  2012-01-11       Impact factor: 2.574

7.  Barcode identifiers as a practical tool for reliable species assignment of medically important black yeast species.

Authors:  Guido Heinrichs; G Sybren de Hoog; Gerhard Haase
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

8.  Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.

Authors:  Jamel Eddouzi; Valérie Hofstetter; Marizeth Groenewald; Mohamed Manai; Dominique Sanglard
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

9.  Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts.

Authors:  A F Schmalreck; M Lackner; K Becker; W Fegeler; V Czaika; H Ulmer; C Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 10.  Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach.

Authors:  Lenka Bašková; Vladimír Buchta
Journal:  Folia Microbiol (Praha)       Date:  2012-05-08       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.